BLLN
NASDAQ HealthcareBillionToOne, Inc. - Class A common stock
Diagnostics & Research
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and types of mutations detected that include deletions, insertions, and point mutations; and Northstar Response, a methylation-based assay that quantifies the amount of cancer at the single molecule level without requiring a tissue biopsy, enabling real-time monitoring of patient response to therapy with unprecedented precision. BillionToOne, Inc. was incorporated in 2016 and is headquartered in Menlo Park, California.
�� 市场数据
| 价格 | $79.43 |
|---|---|
| 成交量 | 493,858 |
| 市值 | 3.65B |
| RSI（14日） | 59.6 |
| 50日均线 | $78.99 |
| 52周最高 | $138.70 |
| 52周最低 | $61.96 |
| 市盈率 | 567.36 |
| Forward P/E | 88.75 |
| Price / Book | 7.58 |
🎯 投资策略评分
BLLN 在各投资策略中的评分。分数越高，越符合该策略目标。
🔍 策略解读
最佳匹配： 🔪 Falling Knife (72/100) — 此策略 逆向投资（超卖 + 低于移动均线）.
评分最低的策略： 🚀 Moon Shot (11/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →
📚 了解更多
在文本中查找 BLLN in your text
粘贴任何文章、记录或帖子 — 工具将提取 BLLN 以及每一个其他隐藏的股票代码。
免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-04-17.